Skip to main content

Type at least 3 characters

19 articles

No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.

Original Research

Published on 26 Jul 2022

Intensification of Insulin Treatment With Insulin Degludec/Aspart in Type 2 Diabetic Patients: A 2-Year Real-World Experience

in Diabetes Therapies

Hatice Oner
Hatice Gizem Gunhan
Dilek Gogas Yavuz

Frontiers in Clinical Diabetes and Healthcare

doi 10.3389/fcdhc.2022.783277

2,304 views
1 citation

Original Research

Published on 05 Jul 2022

A Changed Gut Microbiota Diversity Is Associated With Metabolic Improvements After Duodenal Mucosal Resurfacing With Glucagon-Like-Peptide-1 Receptor Agonist in Type 2 Diabetes in a Pilot Study

in Diabetes Therapies

Suzanne Meiring
Annieke C. G. van Baar
Nikolaj Sørensen
Frits Holleman
Maarten R. Soeters
Max Nieuwdorp
Jacques J. G. H. M. Bergman

Frontiers in Clinical Diabetes and Healthcare

doi 10.3389/fcdhc.2022.856661

3,749 views
12 citations

Original Research

Published on 12 Oct 2021

Dapagliflozin, as Add-on Therapy in Type 2 Diabetes Patients, Is Associated With a Reduction in Albuminuria and Serum Transaminase Levels

in Diabetes Therapies

Silas Benjamin
Manjunath Ramanjaneya
Alexandra E. Butler
Imran Janjua
Firjeeth Paramba
Jafer Palaki
Aisha Al Kubaisi
Prem Chandra
Ibrahem Abdalhakam
Nasseer Ahmad Massodi

Frontiers in Clinical Diabetes and Healthcare

doi 10.3389/fcdhc.2021.733693

2,111 views
1 citation